Research and Grants | The Cure Starts Now

The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.


UCL Institute of Child Health - $200,000

Amount
$200,000.00
Date
December 2015

T-cell based immunotherapy for DIPG.

Dana Farber Cancer Institute - $100,000

Amount
$100,000.00
Date
December 2015

Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma

VU University Medical Center - $92,950

Amount
$92,950.00
Date
November 2015

Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.

Children's Cancer Institute - $145,341

Amount
$145,341.00
Date
November 2015

Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.

Cincinnati Children's Hospital Medical Center - $200,000

Amount
$200,000.00
Date
October 2015

Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas

The Hospital for Sick Children - $190,905

Amount
$190,905.00
Date
October 2015

Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG

Children's National Medical Center - $200,000

Amount
$200,000.00
Date
October 2015

Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models

European DIPG Registry - $445,870.12

Amount
$445,870.00
Date
September 2015

European DIPG Registry.